NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
69452-159-13 | 69452-159 | HUMAN PRESCRIPTION DRUG | Deferasirox | deferasirox | TABLET, FOR SUSPENSION | ORAL | 20180928 | N/A | ANDA | ANDA210920 | Bionpharma Inc. | DEFERASIROX | 125 mg/1 | 30 TABLET, FOR SUSPENSION in 1 BOTTLE (69452-159-13) |
69452-160-13 | 69452-160 | HUMAN PRESCRIPTION DRUG | Deferasirox | deferasirox | TABLET, FOR SUSPENSION | ORAL | 20180928 | N/A | ANDA | ANDA210920 | Bionpharma Inc. | DEFERASIROX | 250 mg/1 | 30 TABLET, FOR SUSPENSION in 1 BOTTLE (69452-160-13) |
69452-161-13 | 69452-161 | HUMAN PRESCRIPTION DRUG | Deferasirox | deferasirox | TABLET, FOR SUSPENSION | ORAL | 20180928 | N/A | ANDA | ANDA210920 | Bionpharma Inc. | DEFERASIROX | 500 mg/1 | 30 TABLET, FOR SUSPENSION in 1 BOTTLE (69452-161-13) |